Skip to main content
Clinical Trials/NCT01227005
NCT01227005
Completed
Phase 4

Early Whole Blood in Patients Requiring Transfusion After Major Trauma

The University of Texas Health Science Center, Houston1 site in 1 country107 target enrollmentMay 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Trauma/Injury Problem
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
107
Locations
1
Primary Endpoint
Units of Blood Products Required During the First 24 Hours After Emergency Department Admission
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The proposal will assess if patients who require massive transfusion can be accurately predicted early after emergency department arrival and assess if the use of stored whole blood during initial resuscitation will reduce transfusion needs compared to transfusion with component therapy and thus improve outcome.

Detailed Description

Background: The acquired coagulopathy of trauma is responsible for a large percentage of early deaths in civilian trauma practice and is a major cause of battlefield mortality. Widespread recognition has provided a rationale for fundamental changes in the initial management of severely injured patients through prevention of hypothermia, damage control surgery, massive transfusion protocols and early triage to intensive care units for optimized resuscitation. Despite these major advances, hemorrhage remains a leading cause of early death in both civilian trauma and military combat casualty care. However, it is unclear how early whole blood will affect coagulopathy in this cohort of patients as compared to the current standard of care. Objective/Hypothesis: The proposal will assess if patients who require massive transfusion can be accurately predicted early after emergency department arrival and assess if the use of stored whole blood during initial resuscitation will reduce transfusion needs compared to transfusion with component therapy and thus improve outcome. Study Design: As a first step in testing this hypothesis, we will test commonly utilized point of care analysis devices and determine their reliability in predicting transfusion requirements in severely injured trauma patients within 20 minutes after arrival in the emergency department. Furthermore, we will prospectively randomize severely injured patients who require a blood transfusion to receive either stored whole blood and pooled platelets or component therapy (packed red blood cells, fresh frozen plasma, and platelets, our current standard of care) and compare the ability of stored whole blood to reduce transfusion needs and improve clinical outcomes. Relevance: Severe uncontrollable coagulopathy in major trauma patients continues to be a major determinant of trauma mortalities. The proposed effort aims to provide an early, coagulopathy-based prediction model to identify patients at risk for massive transfusion. Moreover, our proposal intends to evaluate early stored whole blood transfusion in this at risk patient population and determine stored whole blood's ability to prevent or control severe coagulopathy compared to standard transfusion care.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
December 2012
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bryan Cotton

Associate Professor, Surgery

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older.
  • Meet Code 3 status; Code 3 is determined by the following criteria (Patients must meet at least one of the following physiologic and/or anatomic criteria):
  • Physiologic criteria indicating high risk or life threatening injuries
  • GCS \<10 (Glasgow Coma Scale)
  • SBP \<90 (Systolic blood pressure)
  • RR \<10 or \>29 (Respiratory rate)
  • HR \>120 (Heart rate)
  • intubated
  • Base Deficit \> 6
  • Anatomic criteria indicating high risk or life threatening injuries

Exclusion Criteria

  • Death thought to be imminent, suggesting a futile resuscitation effort
  • Known or assumed religious objection to blood products
  • Do not resuscitate order in place
  • Women who present to the ED who are obviously pregnant.
  • Patients who appear to the ED wearing the -opt-out‖ bracelet provided at the community consultation.

Outcomes

Primary Outcomes

Units of Blood Products Required During the First 24 Hours After Emergency Department Admission

Time Frame: first 24 hours after ED admission

Compare the ability of whole blood to reduce initial 24-hour transfusion requirements as compared to component therapy (red blood cells, plasma, and platelet units)

Secondary Outcomes

  • 24-hour Mortality(First 24 hours after ED admission)
  • 30-day Mortality(first 30 days after ED admission)

Study Sites (1)

Loading locations...

Similar Trials